Beranda › Kanker Paru › North Dakota › Bismarck
Uji klinis Kanker Paru di Bismarck, ND
9 studi untuk Kanker Paru mencari peserta di lokasi sekitar Bismarck (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Menerima pesertaFase 3
- Sanford Bismarck Medical Center, Bismarck
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Sanford Bismarck Medical Center, Bismarck
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Sanford Bismarck Medical Center, Bismarck
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Sanford Bismarck Medical Center, Bismarck
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Sanford Bismarck Medical Center, Bismarck
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Sanford Bismarck Medical Center, Bismarck
Promoting Radon Testing Among Mothers of Young Children
Menerima pesertaSukarelawan sehat diterima
- University of North Dakota Center for Family Medicine, Bismarck Clinic, Bismarck
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Sanford Bismarck Medical Center, Bismarck
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Sanford Bismarck Medical Center, Bismarck
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Arlington, VA41 studi
- Washington, DC41 studi
- Chicago, IL41 studi
- Baltimore, MD40 studi
- Nashville, TN40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Bismarck
- Kanker Paru Non-Sel Kecil6 studi
- Karsinoma Sel Skuamosa Kepala dan Leher5 studi
- Kanker Payudara3 studi
- Kanker Pankreas3 studi
- Kanker Rektum3 studi
- Kanker Kolon3 studi
- Kanker Prostat3 studi
- Kanker Hipofaring3 studi
- Kanker Laring3 studi
- Kanker Mulut3 studi
- Kanker Kolorektal3 studi
- Melanoma3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.